These data suggest that the presence of C-peptide maintains glucagon secretion during isoglycemia and enhances it during hypoglycemia, which explains why T1DM patients with residual insulin secretory capacity are less susceptible to hypoglycemia. Here, GCG is linked to Hypoglycemia.